Epidemiology of HIV-associated malignancies;Épidémiologie des tumeurs malignes associées à l'infection par le VIH

Bulletin du Cancer

Volumn 90, Issue 5, 2003, Pages 387-392

  Launay, Odile ^a,b   Guillevin, Loïc ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

Aids; HIV; Malignancy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVASIVE CARCINOMA; KAPOSI SARCOMA; NONHODGKIN LYMPHOMA; ONCOVIRINAE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REVIEW; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS; ANUS TUMOR; B CELL LYMPHOMA; FEMALE; INCIDENCE; PREVALENCE; UTERINE CERVIX TUMOR; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; PREVALENCE; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0042706974     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996; 10: 997-1010.
2. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer 1997; 73: 645-50.
3. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27: 390-401.
4. Penn I. Tumors of the immunocompromised patient. Annu Rev Med 1988; 39: 63-73.
5. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002; 16: 441-59.
6. DeMario MD, Liebowitz DN. Lymphomas in immunocompromised patients. Semin Oncol 1998; 25: 492-502.
7. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-45.
8. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001; 154: 544-56.
9. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992; 41: 1-19.
10. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-9.
11. Dal Maso L, Serraino D, Franceschi S. Epidemiology of HIV-associated malignancies in developed and developing countries. Eur J Cancer 2001; 37: 1188-201.
12. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Br J Cancer 1998; 78: 966-70.
13. Spano JP, Atlan D, Breau JL, Farge D. AIDS and non-AIDS related malignancies: a new vexing challenge in HIV-positive patients. Part I. Kaposi's sarcoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. Eur J Intern Med 2002; 13: 170-9.
14. Spano JP, Atlan D, Breau JL, Farge D. AIDS and non-AIDS related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancers. Eur J Intern Med 2002; 13: 227-32.
15. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16: 1155-61.
16. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10.
17. Hamilton-Dutoit SJ, Raphael M, Audoin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in AIDS-related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 82: 619-24.
18. Chang Y, Ceserman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
19. Palella FJ, Delaney KM, Mootman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
20. Moctoft A, Vella S, Benfield TL, et al. Changing patterns of mortality accross Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-30.
21. International Collaboration on HIV and Cancer. Highly active antiretrovital therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 1823-30.
22. Buchbinder SP, Holmberg SD, Scheet S, Colfax G, O'Malley P, Vittinghoff E. Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 1999; 21 (suppl. 1): S23-6.
23. Jacobson LP, Yamashita TE, Detels R, et al. Impact of potent antiretrovital therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1999; 21 (suppl. 1): S34-41.
24. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaff HW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 1999; 21: S11-7.
25. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Br Med J 1999; 319: 23-4.
26. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003; 4: 110-9.
27. Matthews GV, Bower M, Mandalie S, et al. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000; 96: 2730-4.
28. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 96: 2339-44.
29. Franceschi S, Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population. Tumori 1995; 81: 308-14.
30. Franceschi S, Dal Maso L, Lo Re A, Serraino D, La Vecchia C. Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-1994. Br J Cancer 1997; 76: 114-7.
31. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men- New York City and California. Morb Mortal Wkly Rep 1981; 30: 305-8.
32. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection ? Lancet 1990; 335: 123-8.
33. Gaidano G, Capello D, Carbone A. The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis. Semin Oncol 2000; 27: 431-41.
34. Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma: prognostic factors predicting of survival. Cancer 1991; 68: 2466-72.
35. Schwartlander B, Horsburgh CR, Hamouda O, Skarabis H, Koch MA. Changes in the spectrum of AIDS-defining conditions and decrease in CD4 + lymphocyte counts as AIDS manifestation in Germany from 1986-1991. AIDS 1992; 6: 413-20.
36. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphomas in San Francisco. JAMA 1989; 261: 719-24.
37. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
38. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD 138/syndecan-1 and Epstein Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of AIDS-related non-Hodgkin's lymphoma. Blood 1998; 91: 747-55.
39. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001; 98: 3406-12.
40. Gerard L, Galicier L, Boulanget E, Quint L, Lebrette MG, Mortier E, et al. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 2003; 17: 81-7.
41. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993; 71: 402-6.
42. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990; 38: 377-82.
43. Serraino D, Dal Maso L, La Vecchia C, Franceschi S. Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS 2002; 16: 781-6.
44. Parazzini F, Chatenoud L, La Vecchia C, Negri E, Francheschi S, Bolis G. Determinants of risk of invasive cervical cancer in young women. Br J Cancer 1998; 77: 838-41.
45. Serraino D, Napoli PA, Zaccarelli M, Alliegro MB, Pezzotti P, Rezza G. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS 1996; 10: 1041-2.
46. Serraino D, Carrieri P, Pradier C, et al. Risk of invasive cervical cancer among women with or at risk for, HIV infection. Int J Cancer 1999; 82: 334-7.
47. Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosupression and high human papillomavirus load. Obstet Gynecol 2000; 96: 403-9.
48. Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, ShahK. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and seronegative women. Am J Epidemiol 2000; 151: 1148-57.
49. Lillo FB, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184: 547-51.
50. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytological changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15: 2157-64.
51. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16: 1799-802.
52. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359: 108-13.
53. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994; 139: 772-80.
54. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994; 8: 283-95.
55. Spina M, Sandri S, Tirelli U. Hodgkin's disease in HIV-1 infected individuals. Curr Opin Oncol 1999; 11: 522-6.
56. McClain KL, Joshi VV, Murphy SB. Cancers in children with HIV infection. Hematol Oncol Clin North Am 1996; 10: 1189-201.
57. Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in chidren with AIDS. JAMA 2000; 284: 205-9.
58. Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected chidren: a case series from the Children's Cancer Group ant the National Cancer Institute. J Clin Oncol 1998; 16: 1729-35.